Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations

Mod Pathol. 2002 Jun;15(6):599-605. doi: 10.1038/modpathol.3880572.

Abstract

The genetic alterations of appendiceal carcinomas have not been reported in detail. We studied the clinicopathological factors and genetic alterations including microsatellite instability, p53 overexpression, and mutations of the K-ras proto-oncogene of 30 appendiceal adenocarcinomas, consisting of 23 mucinous and 7 nonmucinous carcinomas. Sixteen (70%) mucinous carcinomas presented with pseudomyxoma peritonei, but 6 of 7 (86%) nonmucinous carcinomas presented with appendicitis (P =.002). All carcinomas were microsatellite stable, and p53 overexpression was present in only 1 of 30 (3%) carcinomas. K-ras mutation was present in 11 of 20 (55%) carcinomas, including 8 of 16 (50%) mucinous and 3 of 4 (75%) nonmucinous carcinomas. The mean survival of patients with mucinous carcinomas was 26 +/- 19 months compared with 13 +/- 9 months for patients with nonmucinous carcinomas (P =.0002). Our findings suggest that mucinous and nonmucinous carcinomas of appendix have similar genetic alterations, but different clinical presentation and prognosis.

MeSH terms

  • Adenocarcinoma / genetics
  • Adenocarcinoma / metabolism
  • Adenocarcinoma / pathology*
  • Adenocarcinoma, Mucinous / genetics
  • Adenocarcinoma, Mucinous / metabolism
  • Adenocarcinoma, Mucinous / pathology*
  • Adult
  • Aged
  • Appendiceal Neoplasms / genetics
  • Appendiceal Neoplasms / metabolism
  • Appendiceal Neoplasms / pathology*
  • Base Sequence
  • DNA Mutational Analysis
  • DNA, Neoplasm / chemistry
  • DNA, Neoplasm / genetics
  • Female
  • Genes, ras / genetics
  • Humans
  • Immunohistochemistry
  • Male
  • Microsatellite Repeats
  • Middle Aged
  • Mutation
  • Mutation, Missense
  • Proto-Oncogene Mas
  • Survival Analysis
  • Tumor Suppressor Protein p53 / biosynthesis

Substances

  • DNA, Neoplasm
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Tumor Suppressor Protein p53